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ABSTRACT
Objective: Evaluate the post-operative treatment of CTS, 
using the LLLT. Method: We prospectively evaluated 58 pa-
tients with CTS, randomly divided into two groups: treat-
ment with LLLT (Group 1) and placebo (Group 2). A 830 nm 
gallium-aluminum-arsenic laser was used, with a power of 30 
mW. Results: There was female predominance in both groups. 
The mean age of the patients in Group 1 was 44.3 years and in 
Group 2, 51.9 years. The average duration of disease progres-
sion was around two years in both groups. The average time 
elapsed since discharge from treatment was 3.6 months in 
both groups, and fewer patients had postoperative complaints 
in Group 1 than in Group 2. At the end of the treatment, in 
Group 1, 29.41% of the patients presented electromyographic 
abnormalities, while in Group 2, 63.64% of the patients had 
abnormalities, after six months. Conclusion: This was an ini-
tial study on adjuvant therapy using postoperative LLLT on 
CTS. The method presented was sufficient for postoperative 
evaluation of the patients in this study. Patients undergoing 
LLLT after surgery for CTS were benefited and had better 
functional outcomes than shown by the control group. The 
technique was effective and did not have any adverse effects 
on the patients studied. 
Keywords - Carpal Tunnel Syndrome; Median Neuropathy; 
Laser Therapy, Low-Level; Postoperative Period
INTRODUCTION
Carpal tunnel syndrome (CTS) is a disease cha-
racterized by compression of the median nerve 
when this passes below the flexor retinaculum of 
the wrist, and is associated with functional altera-
tions of the nerve(1).
Individuals with the disease in an advanced sta-
ge present the median nerve extended in the region 
proximal to the carpal tunnel and stenosed inside the 
tunnel, with a bluish coloration, typical of chronic 
ischemia. Atrophy of the thenar region may be pre-
sent in these cases(1).
Patients usually complain about progressive loss 
of strength in the hand, especially in thumb oppo-
nency, paresthesia in median nerve sensory distribu-
tion and pain in the palmar region, with characteris-
tic nighttime pain that causes awakening from sleep. 
Both hands can be affected, yet the symptoms are 
generally worse in the dominant hand. Middle-aged 
women constitute the majority of patients(1).
The clinical diagnosis is based on the history of the 
disease and physical examination, especially Tinel’s 
sign and the Phalen and Durkan tests. Tinel’s sign is 
verified with digital percussion along the course of 
the median nerve through the carpal tunnel, which 
causes an electric shock sensation in the nerve dis-
tribution territory. Phalen’s test consists of flexion of 
the wrists with the elbows flexed at 90° and shoul-
ders in abduction in the scapular plane of 90°, for 
approximately one minute, causing exacerbation of 
the sensory alterations perceived by the patient(1). 
Compression of the wrist caused by the examiner 
induces pain and also exacerbates the symptoms, and 
is called the Durkan test; it is the most sensitive of 
clinical tests for the disease(2).
Factors associated with the disease include obe-
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sity, hypothyroidism, diabetes mellitus, pregnancy, 
kidney disease, inflammatory arthritis, acromegaly, 
mucopolysaccharidosis, advanced age, smoking and 
extreme, repetitive flexion of the wrist(2). It is neces-
sary to investigate other diseases that cause similar 
symptoms, such as: cervical radiculopathy, lesions 
of the brachial plexus, thoracic outlet syndrome, neo-
plasias of the pulmonary apex, pronator syndrome, 
cubital and ulnar tunnel syndromes and secondary 
peripheral neuropathies.
Electrophysiological evaluations of the median 
nerve, such as nerve conduction velocity and electro-
myography, are used to confirm the clinical diagnosis. 
The decrease in amplitude of the action potential, the 
increase of distal latency and the reduction of nerve 
conduction velocity are findings considered abnor-
mal. Distal motor and sensory latencies above 4.2ms 
and 3.5ms, respectively, are generally considered pa-
rameters of abnormality(3). There are recent studies 
suggesting the complementary use of wrist ultraso-
nography, with measurement of the cross-sectional 
area of the median nerve, as an aid in the diagnosis 
and supervision of CTS treatment(4). Some authors 
relate the disease’s diagnosis and its severity to the re-
sults obtained after evaluation of the self-administered 
Boston questionnaire(5).
Therapeutic methods range from observation of 
disease evolution alone, wrist immobilization and 
local injection of corticosteroids, to surgery(6). Con-
servative treatments have satisfactory results in most 
cases, when the symptoms have been present for less 
than a year(2). Surgery is reserved for cases that are 
refractory to conservative treatment and for those in 
advanced stages of the condition, with atrophy of 
the thenar region or electrophysiological evidence of 
denervation. The complications of surgery are well 
documented in literature and include the persistence 
of symptoms, which is closely related to the surgeon’s 
experience for complete release of the carpal tunnel(2). 
Common concerns in the postoperative period are 
pain, relief of nerve compression symptoms, sensi-
tivity of the scar and time taken to return to work(7).
As an alternative to the conservative treatments 
described for CTS, many studies have investigated 
the results of low-level laser therapy (LLLT) in the 
relief of symptoms and in the functional recovery of 
the median nerve. In patients with slight and moderate 
CTS, Chang verified that laser therapy was effective 
in the relief of pain and symptoms, and improved the 
functional ability of the fingers and strength of the 
hand, not observing side effects(8). Yagci et al(9) com-
pared the treatment using immobilization of the wrist 
and immobilization associated with sessions of low-
level laser therapy in patients with CTS, concluding 
that the electrophysiological parameters were better 
after the associated treatment. A randomized, double-
blind, placebo-controlled Canadian trial, conducted 
with 16 patients with CTS, demonstrated a placebo 
effect of LLLT, and the inefficacy of the therapeutic 
method(10); Bakhtiary and Rashidy-Pour concluded 
that ultrasound is superior to laser therapy in the 
conservative treatment of CTS(11). In the comparison 
between LLLT and surgical release of the carpal tun-
nel for the treatment of CTS, it was concluded that 
laser therapy is effective in initial cases with slight to 
moderate symptoms, when pain is the main symp-
tom present, while surgery is reserved for advanced 
and chronic cases of the disease. These authors also 
suggest using LLLT to relieve residual pain after 
surgical treatment(12).
It is believed that low-level laser radiation stimu-
lates cell proliferation, by a photochemical reaction 
that changes the permeability of the cell membra-
ne. Laser therapy has been used to stimulate the 
healing of wounds, for neuronal regeneration and 
in pain control.
Rochkind et al(13) demonstrated the presence of 
stimulation of cell growth of rat embryo neurons that 
received laser therapy radiation in comparison to a 
control group of non-radiated rats. Gigo-Benato et 
al(14) and Rochkind et al(15) published an extensive 
bibliographic review of experimental basic studies 
that demonstrate the stimulation of laser therapy in 
neuronal growth and in the functional recovery of in-
jured peripheral nerves. A controlled experiment on 
rats assessed the functional recovery of the ischiatic 
nerve and the histology of the nerve after three we-
eks of LLLT for the treatment of surgical crushing 
of the nerves, concluding that the laser effectively 
accelerated neuronal regeneration(16).
This study aims to compare the postoperative 
results of the patients treated with low-level laser 
therapy with those of the patients treated with pla-
cebo laser, in relation to the parameters of pain, 
persistence of symptoms, return to work or to daily 
activities and neurophysiological recovery, observed 
by electroneuromyography.
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CASUISTRY AND METHOD
The study was composed of 58 patients with carpal 
tunnel syndrome treated at the Hand Surgery Outpatient 
Clinic, assessed between May 2009 and January 2011. 
The patients confirmed their agreement to participate in 
the study by signing an informed consent form.
The eligibility criteria of this study included pa-
tients with a clinical and electroneuromyographic 
diagnosis of carpal tunnel syndrome, with normal 
laboratory tests (leukogram, erythrogram, coagulo-
gram, glucose, urea, creatinine, sodium, potassium), 
and wrist radiographs without osteoarticular lesions. 
Individuals already submitted to surgical procedures 
involving the wrist, those who received infiltration at 
the site, pregnant or breastfeeding women, those using 
an experimental drug, patients with active infection, 
or myocardial infarct less than six months earlier or 
other diseases without adequate clinical control were 
excluded from the study.
The surgical technique was the same for all the 
patients from the study, with the classic, longitudinal 
access route, anterior to the flexor retinaculum, with 
release of the flexor retinaculum of the wrist, without 
the performance of median nerve microneurolysis in 
any patient. 
The patients were randomly and sequentially divi-
ded into two groups: group 1 – low-level laser therapy 
(LLLT); group 2 – placebo laser therapy (PLT). The 
treatment was performed in 10 daily, consecutive ses-
sions, with an interval of two days (weekend), using 
a total of three Joules, at three points of the carpal 
tunnel (in the topography of the pisiform bone, in 
the middle of the carpal tunnel and at the distal limit 
of the carpal tunnel). Neither group of patients knew 
the identity of the members of the placebo group or 
treatment group.
The equipment used was the aluminum gallium 
arsenide Ibramed® laser pen, with a wavelength of 
830nm, and power of 30mW.
Both groups were assessed regularly by the sur-
geon after the procedure, in visits two weeks after 
surgery, and in the first, second, third and sixth pos-
toperative months, or until the patients were asymp-
tomatic and capable of returning to work or to their 
activities of daily living. During the visits, they were 
evaluated in terms of symptoms of palmar pain, pillar 
pain, paresthesia, nighttime pain, pain or discomfort 
at the site of the scar and Tinel›s test, as well as time 
taken to return to activities of daily living or to work. 
Electroneuromyography was performed in the sixth 
postoperative month, or when the patient was asymp-
tomatic (if this occurred earlier).
The univariate analysis was conducted using 
Fisher›s exact test to indicate the statistical difference 
between the groups. 
RESULTS
The patients from group 1 totaled 29. They were 
all treated surgically and submitted to low-level laser 
therapy in the wrist during the postoperative period; 
of these, eight were male and 21 female, with ages 
ranging between 25 and 80 years (mean age 44.3 
years), with 17 right wrists and 12 left; the disease 
evolution time ranged between six months and 10 
years (mean time 1.97 years). Group 2 was formed by 
29 patients, four of whom were male and 25 female, 
with ages between 24 and 89 years (mean age 51.9 
years); 19 right wrists and 10 left; the disease evolu-
tion time ranged between six months and 10 years 
(mean time of two years and two months).
The patients were monitored by the surgeon after 
the procedure until the symptom complaints ceased 
and the patients were discharged from the treatment 
program. Thus in both groups the mean time to dis-
charge was 3.6 months, whereas in group 1 it ranged 
from one to six months to discharge, and in group 2 
from one to eight months.
The electroneuromyographic examinations were 
performed before surgery and six months after sur-
gery, except in cases in which the patient had been 
discharged from the treatment program before the six 
months. In group 1, the examination showed abnor-
malities in 100% of the patients at the beginning of 
the treatment and in 29.41% at the end. In group 2, we 
had 92.60% of the patients with neurofunctional al-
terations at the beginning of the treatment and 63.64% 
at the end of the study.
The evaluation of the patients performed at one, 
two, three and six months considered the complaints 
of symptoms and the clinical signs of the disease. The 
results are demonstrated in Table 1, which lists the 
number of patients and the clinical findings over time. 
Figure 1 records the total number of patients from 
both groups with clinical alterations in each evalua-
tion. Figures 2 and 3 individualize the groups and the 
postoperative complaints.
No patient abandoned the study, or declared them-
selves dissatisfied with the treatment. They all re-
700
Figure 1 – 7RWDOQXPEHURISDWLHQWVZLWKFRPSODLQWV IURPERWKJURXSV
*UXSR *UXSR
1àP
HURG
HSD
FLHQW
HV
Preoperative 1st month 2nd month 3rd month 6th month
Nu
m
be
r o
f p
at
ie
nt
s
Rev Bras Ortop. 2011;46(6):697-701
turned to their daily activities and were asymptomatic 
upon medical discharge. 
No complications were observed in relation to the 
surgical procedure, nor did any of the patients from 
the study groups require further surgery.
DISCUSSION
Carpal tunnel syndrome is a frequent disease at or-
thopedic and hand surgery outpatient clinics, with high 
prevalence in the general population. It is the most 
common and most extensively studied compressive 
neuropathy in humans. Failures in conservative treat-
ment lead to a large number of patients submitted to 
surgery.
The experimental model presented in this trial was 
established to propose a method that accelerates the 
functional recovery of patients submitted to surgery 
for the treatment of carpal tunnel syndrome, testing 
its efficacy. The search in medical literature did not 
produce any trial that could test the efficacy of low-
level laser therapy in the postoperative state of carpal 
tunnel syndrome; therefore, the unprecedented nature 
of this study hinders the comparison of our results.
There are several studies that evaluate the posto-
perative results of release of the flexor retinaculum of 
the wrist for the treatment of carpal tunnel syndrome, 
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with high rates of satisfactory results(1,2,7,17). Our sample 
coincides with literature in terms of the predominance 
of female patients, mean age, preoperative symptoms 
and diversity of postoperative complaints.
The analysis of results evidences that patients treated 
with adjuvant laser therapy in the postoperative stage 
had fewer complaints in this period. 
Literature lists a painful scar as the main complaint 
of operated patients. This also occurred in our study; 
however, in the first month, 31.03% of the patients 
from group 1 had such a complaint, against 55.17% 
from group 2. In the following months, references to 
the painful scar symptom were constantly less common 
in group 1 than in group 2. 
Pillar pain is also frequently associated with surgical 
failure, and it was present in our patients’ complaints, yet 
progressively decreased during postoperative follow-up, 
and was nonexistent in group 1 after the sixth month. 
Numbness (paresthesia) was also a frequent com-
plaint, with incidence in 18.96% of the individuals in 
the first month, but in the second month none of them 
noticed such a symptom. 
Nighttime pain was not experienced by any of the 
patients from either one of the groups in the postopera-
tive period. 
Pain in the palmar region was experienced by 
32.76% of the patients in the first month, and to a lesser 
extent in those submitted to phototherapy.
The clinical signs of the disease were still present in 
10.34% of the patients from group 1 in the first month 
and ceased in the following evaluations. 
The neurofunctional evaluations demonstrated bet-
ter results in the patients submitted to LLLT.
The various studies demonstrating the results of 
LLLT in neuronal regeneration and in the conservative 
treatment of CTS led us to believe that laser therapy 
could be useful in the functional recovery process of 
the median nerve and could alleviate the symptoms 
perceived after the surgical procedure. Although it is 
an intuitive process at first, we sought an analytical 
method to test the hypothesis. 
The study design was aimed at controlling treat-
ment with the placebo and there was randomization 
to distribute the participants. We did not achieve the 
necessary structure to exclude the surgeon’s aware-
ness of the group to which the patients belonged. But 
we believe that the fact that only the evaluator knew 
whether the patients were being treated with laser or 
placebo led to slight distortion of results, since the 
evaluated complaints originated from the patients and 
not from subjective evaluations by the examiner. The 
electroneuromyographies were executed by examiners 
who did not come into contact with the study data, and 
thus produced objective results.
CONCLUSIONS
We consider this an initial study on the adjuvant 
therapeutic approach using low-level laser therapy in 
the postoperative period of carpal tunnel syndrome. 
Other studies will be necessary to validate the tech-
nique. 
We concluded that the methodology presented was 
sufficient for the postoperative evaluation of the pa-
tients from the study. 
The patients submitted to low-level laser therapy 
after surgical release of the flexor retinaculum in the 
wrist benefited from the treatment and obtained better 
functional results than those from the control group.
The technique was effective and without adverse 
effects among our patients.
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